SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RAPEZZI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.990
AS - Asia 10.437
EU - Europa 7.755
SA - Sud America 2.222
AF - Africa 316
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 5
Totale 32.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.591
SG - Singapore 4.556
FI - Finlandia 2.341
IT - Italia 1.908
CN - Cina 1.753
BR - Brasile 1.710
VN - Vietnam 1.346
PL - Polonia 1.192
HK - Hong Kong 1.137
DE - Germania 498
FR - Francia 393
ID - Indonesia 364
GB - Regno Unito 363
RU - Federazione Russa 324
JP - Giappone 293
MX - Messico 222
IN - India 205
AR - Argentina 182
BD - Bangladesh 167
UA - Ucraina 157
NL - Olanda 148
TR - Turchia 124
ZA - Sudafrica 123
CA - Canada 122
SE - Svezia 119
IQ - Iraq 90
EC - Ecuador 84
CO - Colombia 71
AT - Austria 64
PK - Pakistan 58
MY - Malesia 44
SA - Arabia Saudita 43
VE - Venezuela 43
MA - Marocco 41
ES - Italia 39
CL - Cile 38
EG - Egitto 34
PY - Paraguay 32
UZ - Uzbekistan 32
PH - Filippine 28
TN - Tunisia 28
CH - Svizzera 24
AE - Emirati Arabi Uniti 23
BO - Bolivia 22
KE - Kenya 22
JO - Giordania 21
NP - Nepal 21
IE - Irlanda 19
LT - Lituania 19
PE - Perù 19
AU - Australia 18
BE - Belgio 18
UY - Uruguay 17
CZ - Repubblica Ceca 15
KZ - Kazakistan 14
PT - Portogallo 14
GR - Grecia 12
AZ - Azerbaigian 11
BG - Bulgaria 11
SN - Senegal 11
DZ - Algeria 10
HN - Honduras 10
IL - Israele 10
IR - Iran 10
LY - Libia 10
RO - Romania 10
BY - Bielorussia 9
MD - Moldavia 9
TW - Taiwan 9
AL - Albania 8
ET - Etiopia 8
JM - Giamaica 8
KR - Corea 8
LB - Libano 8
NI - Nicaragua 8
OM - Oman 8
RS - Serbia 8
CR - Costa Rica 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
HR - Croazia 6
HU - Ungheria 6
NG - Nigeria 6
PS - Palestinian Territory 6
AO - Angola 5
CI - Costa d'Avorio 5
GE - Georgia 5
KW - Kuwait 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
BH - Bahrain 4
CY - Cipro 4
EE - Estonia 4
MM - Myanmar 4
NZ - Nuova Zelanda 4
PA - Panama 4
SV - El Salvador 4
AM - Armenia 3
GT - Guatemala 3
LV - Lettonia 3
Totale 32.701
Salva come PNG Salva come JPEG
Città #
Singapore 2.599
Helsinki 2.245
Ashburn 1.742
Warsaw 1.177
Hong Kong 1.123
Fairfield 1.009
San Jose 992
Santa Clara 917
Beijing 709
Woodbridge 540
Houston 460
Wilmington 418
Ho Chi Minh City 411
Seattle 373
Cambridge 339
Chandler 335
Princeton 308
Jakarta 290
Council Bluffs 289
Lauterbourg 282
Hanoi 268
Tokyo 266
Ann Arbor 190
New York 190
Dallas 171
Los Angeles 170
Milan 170
Rome 161
São Paulo 149
Mexico City 148
Moscow 144
Munich 137
San Diego 137
Chicago 123
London 113
Jacksonville 105
Dong Ket 93
Shanghai 92
Nuremberg 80
Bologna 68
Ferrara 62
Rio de Janeiro 62
Turku 56
Frankfurt am Main 54
Haiphong 53
Orem 52
Falls Church 51
Naples 51
Da Nang 50
Tianjin 49
Baghdad 43
Johannesburg 43
Stockholm 43
Boardman 42
Florence 41
Belo Horizonte 40
Denver 39
Montreal 38
Chennai 37
Brooklyn 36
Nanjing 34
Palermo 34
Atlanta 33
Toronto 33
Izmir 32
Buffalo 31
Quito 31
Redwood City 31
Tashkent 31
Bremen 30
Dhaka 30
Brasília 29
Guangzhou 29
Phoenix 29
Bari 28
Poplar 28
Manchester 27
Biên Hòa 26
Hải Dương 26
Norwalk 26
Salt Lake City 26
Campinas 24
Guayaquil 24
Lahore 23
Boston 22
Vienna 22
Amman 21
Medellín 21
Porto Alegre 21
Turin 21
Buenos Aires 20
Curitiba 20
Mountain View 20
Bogotá 19
Lappeenranta 19
San Francisco 19
Ankara 18
Kuala Lumpur 18
New Delhi 18
Bắc Ninh 17
Totale 21.486
Salva come PNG Salva come JPEG
Nome #
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications 2.008
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 819
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 458
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 425
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 229
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 222
Heart failure with preserved ejection fraction: uncertainties and dilemmas 220
Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis 209
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 209
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 208
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 198
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 196
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 190
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction 189
Gender-related risk of myocardial involvement in systemic amyloidosis 184
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 182
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 181
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 180
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 179
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role 177
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 175
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? 175
La diagnosi elettrocardiografica di infarto miocardico acuto nell'era dell'angioplastica primaria e delle reti hub and spoke 173
Treatment of cardiac transthyretin amyloidosis: An update 170
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 166
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 166
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis 162
Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications 160
Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis 160
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response 160
Left ventricular myocardial noncompaction with advanced atrioventricular conduction disorder and ventricular arrhythmias in a young patient: Role of MIB1 gene 160
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 159
A targeted proteomics approach to amyloidosis typing 159
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 159
'Corona' versus 'coronary' 156
The Mediterranean diet: a cultural journey 155
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 151
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 150
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis 150
Looking for a tailored therapy for heart failure: Are we capable of treating the patient instead of the disease? 149
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study 148
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice 147
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients with Coronary Stent: How Important Is the Interplay between Stent Type and Time from Stenting to Surgery? 146
Predictors of atrial fibrillation in hypertrophic cardiomyopathy 146
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management 145
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 144
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy 143
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 143
2019 CORONAVIRUS: What are the implications for cardiology? 143
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 142
Well-known and novel players in endothelial dysfunction: Updates on a notch(ed) landscape 142
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis 141
The battle against COVID-19: Mortality in Italy 140
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 140
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 139
The Residual Risk of Cerebral Embolism after Carotid Stenting: The Complex Interplay between Stent Coverage and Aortic Arch Atherosclerosis 139
Cardiac amyloidosis: the great pretender 139
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA) 138
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 136
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 136
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) 135
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis 135
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome - Results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study 133
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis 133
Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression 133
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea 133
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 132
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis 131
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 129
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 127
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology 127
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 126
Zero-fluoroscopy cardiac ablation: Technology is moving forward in complex procedures—A novel workflow for atrial fibrillation 126
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 126
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 125
One year on: The impact of COVID-19 on clinical research 125
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In? 124
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) 123
Myocarditis in COVID-19 patients: current problems 123
Adapting to survive 123
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 123
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man 122
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 121
Long-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic Events 120
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 120
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 119
Atrial Flutter in Patient With Critical COVID-19: Beneficial Effects of Rhythm Control on Respiratory Distress 118
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 117
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 116
Performance of Synthetic Extracellular Volume Fraction in Different Cardiac Phenotypes From a Prospective Cohort of Patients Referred for Cardiac Magnetic Resonance 116
Left atrial structure and function in cardiac amyloidosis 114
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization 113
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy 112
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 112
Dronedarone: Una reale innovazione o solo una valida seconda scelta? Come districarsi tra linee guida, agenzie regolatorie e pratica clinica quotidiana 111
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 110
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics 109
Relative Left Ventricular Apical Sparing of Longitudinal Strain in Cardiac Amyloidosis: Is it Just Amyloid Infiltration? 109
IMPLICAZIONI PRATICHE E NUOVI SCENARI DI PROTEZIONE CARDIOVASCOLARE 109
Novel SCN5A Variant Shows Multiple Phenotypic Expression in the Same Family 108
Totale 17.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 212.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.359
Totale 213.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021853 0 0 0 0 0 0 0 0 0 423 195 235
2021/20221.975 133 87 52 33 73 136 188 188 106 197 209 573
2022/20231.696 323 42 120 92 152 186 124 137 179 86 159 96
2023/20241.368 79 130 74 64 114 122 74 85 49 60 68 449
2024/20256.241 220 88 616 193 650 503 204 184 988 1.227 769 599
2025/202616.899 1.180 712 1.556 2.280 2.083 941 1.648 1.137 3.478 1.884 0 0
Totale 33.534